Xiang-yuan Wu

Entecavir vs lamivudine for prevention of hepatitis B virus reactivation among patients with untreated diffuse large B-cell lymphoma receiving R-CHOP chemotherapy: a randomized clinical trial.

Tongyu Lin, Jun Zhu, S. Ye, 2014, JAMA.

A proposal for a new staging system for extranodal natural killer T-cell lymphoma: a multicenter study from China and Asia Lymphoma Study Group

Weili Zhao, Jie Jin, W. Kim, 2020, Leukemia.

Safety and efficacy of apatinib in patients with advanced gastric or gastroesophageal junction adenocarcinoma after the failure of two or more lines of chemotherapy (AHEAD): a prospective, single-arm, multicenter, phase IV study

Wei Li, F. Gao, Y. Ba, 2023, BMC Medicine.

Oral fludarabine in combination with doxorubicin and dexamethasone as first-line therapy for nodal peripheral T-cell lymphomas: early results of a prospective multicenter study

K. Gu, Yun Fan, Jian Zhang, 2012, Cancer Chemotherapy and Pharmacology.

Dose-Dense Rituximab-CHOP versus Standard Rituximab-CHOP in Newly Diagnosed Chinese Patients with Diffuse Large B-Cell Lymphoma: A Randomized, Multicenter, Open-Label Phase 3 Trial

Chengcheng Guo, Wenyu Li, H. Hong, 2018, Cancer research and treatment : official journal of Korean Cancer Association.